Cancer and Inflammation
Submission Deadline: Apr. 30, 2015
Lead Guest Editor
Mükerrem Betül Yerer-Aycan
Department of Pharmacology,Faculty of Pharmacy,University of Erciyes, Kayseri, Turkey
Guest Editor
Guest Editors play a significant role in a special issue. They maintain the quality of published research and enhance the special issue’s impact. If you would like to be a Guest Editor or recommend a colleague as a Guest Editor of this special issue, please Click here to fulfill the Guest Editor application.
Guidelines for Submission
Manuscripts can be submitted until the expiry of the deadline. Submissions must be previously unpublished and may not be under consideration elsewhere.
Papers should be formatted according to the guidelines for authors (see: By submitting your manuscripts to the special issue, you are acknowledging that you accept the rules established for publication of manuscripts, including agreement to pay the Article Processing Charges for the manuscripts. Manuscripts should be submitted electronically through the online manuscript submission system at All papers will be peer-reviewed. Accepted papers will be published continuously in the journal and will be listed together on the special issue website.
Published Papers
The special issue currently is open for paper submission. Potential authors are humbly requested to submit an electronic copy of their complete manuscript by clicking here.
The link between inflammation and cancer has been suggested by epidemiological and experimental data and confirmed by anti-inflammatory therapies that show efficacy in cancer prevention and treatment. The fact that continuous irritation over long periods of time can lead to cancer had already been described in the traditional Ayurvedic (meaning “the science of long life”) medical system, written as far back as 5000 years ago. Whether this irritation is the same as what Rudolf Virchow referred to as inflammation in the 19th century is uncertain. Virchow first noted that inflammatory cells are present within tumors and that tumors arise at sites of chronic inflammation. This inflammation is now regarded as a “secret killer” for diseases such as cancer. For example, inflammatory bowel diseases such as Crohn disease and ulcerative colitis are associated with increased risk of colon adenocarcinoma, and chronic pancreatitis is related to an increased rate of pancreatic cancer. Taking into account the high relationship between cancer and inflammation it seems to be a necessity to gather this knowledge in a special issue, namely Cancer and Inflammation.
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
Tel: (001)347-983-5186